Harnessing the power of Vδ2 cells in cancer immunotherapy - Test2 - elhamkhani - TriplyDB

Harnessing the power of Vδ2 cells in cancer immunotherapy

Harnessing the power of Vδ2 cells in cancer immunotherapy

http://www.wikidata.org/entity/Q27027547

about

Prevention of Vγ9Vδ2 T Cell Activation by a Vγ9Vδ2 TCR Nanobody.Zoledronic acid renders human M1 and M2 macrophages susceptible to Vδ2(+) γδ T cell cytotoxicity in a perforin-dependent manner.Dual Face of Vγ9Vδ2-T Cells in Tumor Immunology: Anti- versus Pro-Tumoral Activities.Decitabine Inhibits Gamma Delta T Cell Cytotoxicity by Promoting KIR2DL2/3 Expression.A bispecific nanobody approach to leverage the potent and widely applicable tumor cytolytic capacity of Vγ9Vδ2-T cells.In-depth immunophenotyping of patients with glioblastoma multiforme: Impact of steroid treatment.Immunotherapy With Human Gamma Delta T Cells-Synergistic Potential of Epigenetic Drugs?

P2860

Q38728528-C0771934-37CF-4A66-9D0B-23ECA20AA481 Q40213985-13CDBEEC-66A7-49D2-995E-B6E8BA5D3F11 Q50144881-0C113457-CD59-4835-A54C-F1E4510049D3 Q52597632-0A7B31B2-D4DE-4260-891A-AAD9DD077DD1 Q52731753-A49FD282-9991-4D30-B657-8F037039E893 Q52780147-E711D882-F933-46B1-BC4D-E09C09D858C6 Q55030400-757AC497-56F8-45B5-9E68-E385DA685482

P2860

Harnessing the power of Vδ2 cells in cancer immunotherapy

http://www.wikidata.org/entity/Q27027547

description

2015 nî lūn-bûn

@nan

2015 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2015 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

name

Harnessing the power of Vδ2 cells in cancer immunotherapy

@ast

Harnessing the power of Vδ2 cells in cancer immunotherapy

@en

Harnessing the power of Vδ2 cells in cancer immunotherapy

@nl

type

label

Harnessing the power of Vδ2 cells in cancer immunotherapy

@ast

Harnessing the power of Vδ2 cells in cancer immunotherapy

@en

Harnessing the power of Vδ2 cells in cancer immunotherapy

@nl

prefLabel

Harnessing the power of Vδ2 cells in cancer immunotherapy

@ast

Harnessing the power of Vδ2 cells in cancer immunotherapy

@en

Harnessing the power of Vδ2 cells in cancer immunotherapy

@nl

P1433

Q27027547-668338E1-18E0-4926-A279-8BF864D6B760

P1476

Q27027547-FA697266-AF5F-45BA-A740-47A8DF44B22D

P2093

Q27027547-93116CD0-DF21-4C50-8C2E-D97ECCF1CD6D

Q27027547-B8325827-3E6B-4FB0-A831-637AA5EC0535

P2860

Q27027547-13D6EDC0-C9F2-4D96-8F34-58841B87E116

Q27027547-156DBC13-925F-405B-8392-D3BF6AC2CA89

Q27027547-175EE440-499D-4898-B9A1-7B51F50ED27F

Q27027547-181BF151-3876-4332-AE04-F5315BF9C8F6

Q27027547-18A628A9-F1F0-41A0-855F-4820B3268363

Q27027547-18B19FFA-09FF-4F6E-AFFD-753ED65C4A62

Q27027547-1DCFEFAE-13AC-423A-9EF5-79B5B37E5FBB

Q27027547-1E29AAD1-7D14-4D95-BB6F-CCCEBCAA0EB0

Q27027547-1F343716-F3FE-464F-8E57-E9E7730253C8

Q27027547-215CCDAD-C7D4-4733-A168-C163956B5EC2

P304

Q27027547-16537460-6B94-4080-A821-3B8E5914F363

P31

Q27027547-36AB6ADC-CF16-4755-898A-8AA85FF140DA

P356

Q27027547-D93139EB-9954-4E63-BF36-62591E26B42B

P407

Q27027547-D0F36CF3-F014-463F-94CF-4BF69F79966B

P433

Q27027547-DEA7319C-89AE-4958-8436-6A37D7761D92

P478

Q27027547-9AFBA0FB-8523-4153-BA1B-915DD4676EB7

P577

Q27027547-EB8596A1-3D10-4747-8A23-E9C7D4DEBD79

P698

Q27027547-67C387E1-8155-4933-89B2-44C7EAC2D182

P921

Q27027547-C1733B0A-AF4C-4AAE-BE92-893917A231D4

P932

Q27027547-37DC7A46-2B86-493F-A3DD-E77E89729254

P356

P1433

Clinical and Experimental Immunology

P1476

Harnessing the power of Vδ2 cells in cancer immunotherapy

@en

P2093

D. W. Fowler

http://www.w3.org/2001/XMLSchema#string

M. D. Bodman-Smith

http://www.w3.org/2001/XMLSchema#string

P2860

Key implication of CD277/butyrophilin-3 (BTN3A) in cellular stress sensing by a major human γδ T-cell subset

The Intracellular B30.2 Domain of Butyrophilin 3A1 Binds Phosphoantigens to Mediate Activation of Human Vγ9Vδ2 T Cells

Butyrophilin 3A1 binds phosphorylated antigens and stimulates human γδ T cells

Targeting human {gamma}delta} T cells with zoledronate and interleukin-2 for immunotherapy of hormone-refractory prostate cancer

Butyrophilin 3A1 plays an essential role in prenyl pyrophosphate stimulation of human Vγ2Vδ2 T cells

Vgamma9Vdelta2 T cell-mediated recognition of human solid tumors. Potential for immunotherapy of hepatocellular and colorectal carcinomas.

Innate-like gammadelta T cell responses to mycobacterium Bacille Calmette-Guerin using the public V gamma 2 repertoire in Macaca fascicularis.

Characterization of human γδ T lymphocytes infiltrating primary malignant melanomas.

Activating and propagating polyclonal gamma delta T cells with broad specificity for malignancies

Gammadelta T cells: functional plasticity and heterogeneity.

P304

1-10

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/CEI.12564

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

180

http://www.w3.org/2001/XMLSchema#string

P577

2015-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25469879

http://www.w3.org/2001/XMLSchema#string

P921

P932

4367088

http://www.w3.org/2001/XMLSchema#string